Elizabeth Bruckheimer
Directeur Technique/Scientifique/R&D chez PANBELA THERAPEUTICS, INC.
Profil
Elizabeth Bruckheimer is currently the Chief Scientific Officer & Vice President at Panbela Therapeutics, Inc. She previously worked as the Director-Preclinical Development at Champions Oncology, Inc. and as the VP-Drug Development & Regulatory Affairs at Cancer Prevention Pharmaceuticals, Inc. She also worked as an Associate Director & Manager at Systems Medicine, Inc. Dr. Bruckheimer holds a doctorate degree from The University of Texas at Austin and an undergraduate degree from the University of Arizona.
Postes actifs de Elizabeth Bruckheimer
| Sociétés | Poste | Début |
|---|---|---|
| PANBELA THERAPEUTICS, INC. | Directeur Technique/Scientifique/R&D | 01/06/2022 |
Anciens postes connus de Elizabeth Bruckheimer
| Sociétés | Poste | Fin |
|---|---|---|
| CANCER PREVENTION PHARMACEUTICALS INC | Corporate Officer/Principal | 01/01/2022 |
Systems Medicine, Inc.
 Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Corporate Officer/Principal | - |
| CHAMPIONS ONCOLOGY, INC. | Directeur Technique/Scientifique/R&D | - |
Formation de Elizabeth Bruckheimer
| University of Arizona | Undergraduate Degree |
| The University of Texas at Austin | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| CHAMPIONS ONCOLOGY, INC. | Health Technology |
| PANBELA THERAPEUTICS, INC. | Health Technology |
| Entreprise privées | 2 |
|---|---|
Systems Medicine, Inc.
Systems Medicine, Inc. Pharmaceuticals: OtherHealth Technology Systems Medicine, Inc. develops oncology products by integrating predictive cellular pharmacogenomics. The company is based in Tucson, AZ. The company was founded by Jeffrey E. Jacob. Systems Medicine was acquired by CTI BioPharma Corp. on July 31, 2007 for $35 million. | Health Technology |
Cancer Prevention Pharmaceuticals, Inc.
 Cancer Prevention Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Cancer Prevention Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. It engages in the development of therapeutic agents for the treatment and prevention of certain pre-cancerous conditions, orphan diseases and gastrointestinal conditions. The company’s pipeline consists of Gastrointestinal and Orphan. Cancer Prevention Pharmaceuticals was founded by Dr. Frank Meyskens and Gene Gerner in June 9, 2008 and is headquartered in Tucson, AZ. | Health Technology |